C83.14

Clinical Causes: The precise cause of mantle cell lymphoma remains unknown. However, several factors may contribute to its development, including: - Genetic mutations, particularly involving the overexpression of certain genes like CCND1. - Age, as it predominantly affects middle-aged and older adults. - Gender, with a higher incidence observed in males. - History of other lymphoid malignancies or autoimmune diseases. - Environmental exposures, such as certain pesticides and chemicals, though evidence is limited. - Family history of lymphomas, suggesting a potential genetic predisposition. It is important to note that these factors increase the risk but do not guarantee the development of the disease.

Key Symptoms: Mantle cell lymphoma involving the axillary and upper limb lymph nodes may present with various signs and symptoms, including: - Swelling or painless enlargement of lymph nodes in the armpits and upper arms. - Fatigue and weakness. - Unexplained weight loss. - Fever or night sweats. - Persistent or recurring infections. - Sometimes, symptoms related to pressure effects if lymph nodes enlarge significantly. The symptoms can be subtle initially and may progress over time, emphasizing the importance of medical evaluation if abnormalities are observed.

Diagnosis Path: Diagnosing mantle cell lymphoma involves several steps to confirm the presence of lymphoma and determine its extent: - Physical examination focusing on lymph node regions. - Imaging studies such as CT scans or PET scans to evaluate enlarged lymph nodes and assess spread. - Lymph node biopsy, typically an excisional procedure, to examine tissue morphology. - Histopathological analysis identifying characteristic features of mantle cell lymphoma. - Immunophenotyping tests to detect specific markers like Cyclin D1, which is overexpressed in this disease. - Bone marrow biopsy might be performed to assess whether the marrow is involved. - Additional blood tests and staging procedures to gauge overall health and disease spread. Accurate diagnosis is crucial for formulating an effective treatment plan.

Treatment Protocols: Management of mantle cell lymphoma usually involves a combination of therapies tailored to the individual’s disease stage and overall health: - Chemotherapy, often combined with targeted therapies. - Immunotherapy, including monoclonal antibodies such as rituximab. - Targeted agents like BTK inhibitors for specific cases. - Radiation therapy may be considered for localized lymph node involvement. - Stem cell transplantation might be an option for eligible patients. - Supportive care, including infection prevention and management of side effects. Given the complexity of the disease, a multidisciplinary approach is commonly adopted to optimize outcomes and improve quality of life.